List With HCPCS Codes For Chemotherapy Drugs

The HCPCS codes for Chemotherapy Drugs J9000-J9999 cover a wide range of injectable medications used in chemotherapy treatments. These codes describe various drugs used to treat different types of cancer, including doxorubicin hydrochloride, aldesleukin, arsenic trioxide, asparaginase, atezolizumab, azacitidine, and many others.

1. HCPCS Code J9000

HCPCS J9000 describes the injection of doxorubicin hydrochloride, a chemotherapy drug used to treat various types of cancer.

2. HCPCS Code J9015

HCPCS J9015 describes the injection of aldesleukin, a medication used to treat metastatic renal cell carcinoma and metastatic melanoma.

3. HCPCS Code J9017

HCPCS J9017 describes the injection of arsenic trioxide, a chemotherapy drug used to treat acute promyelocytic leukemia.

4. HCPCS Code J9019

HCPCS J9019 describes the injection of asparaginase (Erwinaze), an enzyme used to treat acute lymphoblastic leukemia.

5. HCPCS Code J9020

HCPCS J9020 describes the injection of asparaginase, not otherwise specified, a medication used to treat acute lymphoblastic leukemia.

6. HCPCS Code J9021

HCPCS J9021 describes the injection of asparaginase, recombinant (rylaze), a medication used to treat acute lymphoblastic leukemia.

7. HCPCS Code J9022

HCPCS J9022 describes the injection of atezolizumab, a medication used to treat various types of cancer, including bladder cancer and lung cancer.

8. HCPCS Code J9023

HCPCS J9023 describes the injection of avelumab, a medication used to treat various types of cancer, including Merkel cell carcinoma and urothelial carcinoma.

9. HCPCS Code J9025

HCPCS J9025 describes the injection of azacitidine, a medication used to treat myelodysplastic syndromes and acute myeloid leukemia.

10. HCPCS Code J9027

HCPCS J9027 describes the injection of clofarabine, a chemotherapy drug used to treat acute lymphoblastic leukemia.

11. HCPCS Code J9029

HCPCS J9029 describes the injection of nadofaragene firadenovec-vncg, a gene therapy used to treat non-muscle invasive bladder cancer.

12. HCPCS Code J9030

HCPCS J9030 describes the live intravesical instillation of BCG (Bacillus Calmette-Guérin), a treatment for bladder cancer.

13. HCPCS Code J9032

HCPCS J9032 describes the injection of belinostat, a chemotherapy drug used to treat peripheral T-cell lymphoma.

14. HCPCS Code J9033

HCPCS J9033 describes the injection of bendamustine HCL (treanda), a chemotherapy drug used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

15. HCPCS Code J9034

HCPCS J9034 describes the injection of bendamustine HCL (bendeka), a chemotherapy drug used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

16. HCPCS Code J9035

HCPCS J9035 describes the injection of bevacizumab, a medication used to treat various types of cancer, including colorectal cancer and lung cancer.

17. HCPCS Code J9036

HCPCS J9036 describes the injection of bendamustine hydrochloride (Belrapzo), a chemotherapy drug used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

18. HCPCS Code J9037

HCPCS J9037 describes the injection of belantamab mafodontin-blmf, a medication used to treat multiple myeloma.

19. HCPCS Code J9039

HCPCS J9039 describes the injection of blinatumomab, a medication used to treat acute lymphoblastic leukemia.

20. HCPCS Code J9040

HCPCS J9040 describes the injection of bleomycin sulfate, a chemotherapy drug used to treat various types of cancer, including testicular cancer and Hodgkin lymphoma.

21. HCPCS Code J9250

HCPCS J9250 describes the injection of methotrexate sodium, a chemotherapy drug used to treat various types of cancer, including breast cancer and leukemia.

22. HCPCS Code J9255

HCPCS J9255 describes the injection of methotrexate (accord), a chemotherapy drug used to treat various types of cancer, including breast cancer and leukemia.

23. HCPCS Code J9258

HCPCS J9258 describes the injection of paclitaxel protein-bound particles (teva), a chemotherapy drug used to treat various types of cancer, including breast cancer and lung cancer.

24. HCPCS Code J9259

HCPCS J9259 describes the injection of paclitaxel protein-bound particles (american regent), a chemotherapy drug used to treat various types of cancer, including breast cancer and lung cancer.

25. HCPCS Code J9260

HCPCS J9260 describes the injection of methotrexate sodium, a chemotherapy drug used to treat various types of cancer, including breast cancer and leukemia.

26. HCPCS Code J9261

HCPCS J9261 describes the injection of nelarabine, a chemotherapy drug used to treat T-cell acute lymphoblastic leukemia.

27. HCPCS Code J9262

HCPCS J9262 describes the injection of omacetaxine mepesuccinate, a chemotherapy drug used to treat chronic myeloid leukemia.

28. HCPCS Code J9263

HCPCS J9263 describes the injection of oxaliplatin, a chemotherapy drug used to treat colorectal cancer.

29. HCPCS Code J9264

HCPCS J9264 describes the injection of paclitaxel protein-bound particles, a chemotherapy drug used to treat various types of cancer, including breast cancer and lung cancer.

30. HCPCS Code J9266

HCPCS J9266 describes the injection of pegaspargase, a chemotherapy drug used to treat acute lymphoblastic leukemia.

31. HCPCS Code J9267

HCPCS J9267 describes the injection of paclitaxel, a chemotherapy drug used to treat various types of cancer, including breast cancer and lung cancer.

32. HCPCS Code J9268

HCPCS J9268 describes the injection of pentostatin, a chemotherapy drug used to treat hairy cell leukemia.

33. HCPCS Code J9269

HCPCS J9269 describes the injection of tagraxofusp-erzs, a medication used to treat blastic plasmacytoid dendritic cell neoplasm.

34. HCPCS Code J9270

HCPCS J9270 describes the injection of plicamycin, a medication used to treat testicular cancer and hypercalcemia of malignancy.

35. HCPCS Code J9271

HCPCS J9271 describes the injection of pembrolizumab, a medication used to treat various types of cancer, including melanoma and lung cancer.

36. HCPCS Code J9272

HCPCS J9272 describes the injection of dostarlimab-gxly, a medication used to treat endometrial cancer.

37. HCPCS Code J9273

HCPCS J9273 describes the injection of tisotumab vedotin-tftv, a medication used to treat cervical cancer.

38. HCPCS Code J9274

HCPCS J9274 describes the injection of tebentafusp-tebn, a medication used to treat metastatic uveal melanoma.

39. HCPCS Code J9280

HCPCS J9280 describes the injection of mitomycin, a chemotherapy drug used to treat various types of cancer, including bladder cancer and stomach cancer.

40. HCPCS Code J9281

HCPCS J9281 describes the pyelocalyceal instillation of mitomycin, a treatment for upper urinary tract urothelial carcinoma.

41. HCPCS Code J9285

HCPCS J9285 describes the injection of olaratumab, a medication used to treat soft tissue sarcoma.

42. HCPCS Code J9286

HCPCS J9286 describes the injection of glofitamab-gxbm, a medication used to treat non-Hodgkin lymphoma.

43. HCPCS Code J9293

HCPCS J9293 describes the injection of mitoxantrone hydrochloride, a chemotherapy drug used to treat various types of cancer, including breast cancer and leukemia.

44. HCPCS Code J9294

HCPCS J9294 describes the injection of pemetrexed (hospira), a chemotherapy drug used to treat various types of cancer, including lung cancer and mesothelioma.

45. HCPCS Code J9295

HCPCS J9295 describes the injection of necitumumab, a medication used to treat non-small cell lung cancer.

46. HCPCS Code J9296

HCPCS J9296 describes the injection of pemetrexed (accord), a chemotherapy drug used to treat various types of cancer, including lung cancer and mesothelioma.

47. HCPCS Code J9297

HCPCS J9297 describes the injection of pemetrexed (sandoz), a chemotherapy drug used to treat various types of cancer, including lung cancer and mesothelioma.

48. HCPCS Code J9298

HCPCS J9298 describes the injection of nivolumab and relatlimab-rmbw, a combination therapy used to treat advanced melanoma.

49. HCPCS Code J9299

HCPCS J9299 describes the injection of nivolumab, a medication used to treat various types of cancer, including melanoma and lung cancer.

50. HCPCS Code J9301

HCPCS J9301 describes the injection of obinutuzumab, a medication used to treat various types of cancer, including chronic lymphocytic leukemia and non-Hodgkin lymphoma.

51. HCPCS Code J9302

HCPCS J9302 describes the injection of ofatumumab, a medication used to treat chronic lymphocytic leukemia.

52. HCPCS Code J9303

HCPCS J9303 describes the injection of panitumumab, a medication used to treat colorectal cancer.

53. HCPCS Code J9304

HCPCS J9304 describes the injection of pemetrexed (pemfexy), a chemotherapy drug used to treat various types of cancer, including lung cancer and mesothelioma.

54. HCPCS Code J9305

HCPCS J9305 describes the injection of pemetrexed, not otherwise specified, a chemotherapy drug used to treat various types of cancer, including lung cancer and mesothelioma.

55. HCPCS Code J9306

HCPCS J9306 describes the injection of pertuzumab, a medication used to treat HER2-positive breast cancer.

56. HCPCS Code J9307

HCPCS J9307 describes the injection of pralatrexate, a chemotherapy drug used to treat peripheral T-cell lymphoma.

57. HCPCS Code J9308

HCPCS J9308 describes the injection of ramucirumab, a medication used to treat various types of cancer, including gastric cancer and lung cancer.

58. HCPCS Code J9309

HCPCS J9309 describes the injection of polatuzumab vedotin-piiq, a medication used to treat diffuse large B-cell lymphoma.

59. HCPCS Code J9311

HCPCS J9311 describes the injection of rituximab and hyaluronidase, a combination therapy used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

60. HCPCS Code J9312

HCPCS J9312 describes the injection of rituximab, a medication used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

61. HCPCS Code J9041

HCPCS J9041 describes the injection of bortezomib, a medication used to treat multiple myeloma and mantle cell lymphoma.

62. HCPCS Code J9042

HCPCS J9042 describes the injection of brentuximab vedotin, a medication used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

63. HCPCS Code J9043

HCPCS J9043 describes the injection of cabazitaxel, a chemotherapy drug used to treat metastatic castration-resistant prostate cancer.

64. HCPCS Code J9045

HCPCS J9045 describes the injection of carboplatin, a chemotherapy drug used to treat various types of cancer, including ovarian cancer and lung cancer.

65. HCPCS Code J9046

HCPCS J9046 describes the injection of bortezomib (dr. reddy’s), a medication used to treat multiple myeloma and mantle cell lymphoma.

66. HCPCS Code J9047

HCPCS J9047 describes the injection of carfilzomib, a medication used to treat multiple myeloma.

67. HCPCS Code J9048

HCPCS J9048 describes the injection of bortezomib (fresenius kabi), a medication used to treat multiple myeloma and mantle cell lymphoma.

68. HCPCS Code J9049

HCPCS J9049 describes the injection of bortezomib (hospira), a medication used to treat multiple myeloma and mantle cell lymphoma.

69. HCPCS Code J9050

HCPCS J9050 describes the injection of carmustine, a chemotherapy drug used to treat various types of cancer, including brain tumors and lymphomas.

70. HCPCS Code J9051

HCPCS J9051 describes the injection of bortezomib (maia), a medication used to treat multiple myeloma and mantle cell lymphoma.

71. HCPCS Code J9052

HCPCS J9052 describes the injection of carmustine (accord), a chemotherapy drug used to treat various types of cancer, including brain tumors and lymphomas.

72. HCPCS Code J9055

HCPCS J9055 describes the injection of cetuximab, a medication used to treat various types of cancer, including colorectal cancer and head and neck cancer.

73. HCPCS Code J9056

HCPCS J9056 describes the injection of bendamustine hydrochloride (vivimusta), a chemotherapy drug used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

74. HCPCS Code J9057

HCPCS J9057 describes the injection of copanlisib, a medication used to treat follicular lymphoma and marginal zone lymphoma.

75. HCPCS Code J9058

HCPCS J9058 describes the injection of bendamustine hydrochloride (apotex), a chemotherapy drug used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

76. HCPCS Code J9059

HCPCS J9059 describes the injection of bendamustine hydrochloride (baxter), a chemotherapy drug used to treat various types of cancer, including non-Hodgkin lymphoma and chronic lymphocytic leukemia.

77. HCPCS Code J9060

HCPCS J9060 describes the injection of cisplatin, a chemotherapy drug used to treat various types of cancer, including testicular cancer and bladder cancer.

78. HCPCS Code J9061

HCPCS J9061 describes the injection of amivantamab-vmjw, a medication used to treat non-small cell lung cancer with EGFR exon 20 insertion mutations.

79. HCPCS Code J9063

HCPCS J9063 describes the injection of mirvetuximab soravtansine-gynx, a medication used to treat ovarian cancer.

80. HCPCS Code J9064

HCPCS J9064 describes the injection of cabazitaxel (sandoz), a chemotherapy drug used to treat metastatic castration-resistant prostate cancer.

81. HCPCS Code J9065

HCPCS J9065 describes the injection of cladribine, a chemotherapy drug used to treat hairy cell leukemia.

82. HCPCS Code J9070

HCPCS J9070 describes the injection of cyclophosphamide, a chemotherapy drug used to treat various types of cancer, including breast cancer and lymphomas.

83. HCPCS Code J9071

HCPCS J9071 describes the injection of cyclophosphamide (auromedics), a chemotherapy drug used to treat various types of cancer, including breast cancer and lymphomas.

84. HCPCS Code J9072

HCPCS J9072 describes the injection of cyclophosphamide (dr. reddy’s), a chemotherapy drug used to treat various types of cancer, including breast cancer and lymphomas.

85. HCPCS Code J9098

HCPCS J9098 describes the injection of cytarabine liposome, a chemotherapy drug used to treat acute myeloid leukemia.

86. HCPCS Code J9100

HCPCS J9100 describes the injection of cytarabine, a chemotherapy drug used to treat various types of cancer, including leukemia and lymphomas.

87. HCPCS Code J9118

HCPCS J9118 describes the injection of calaspargase pegol-mknl, an enzyme used to treat acute lymphoblastic leukemia.

88. HCPCS Code J9119

HCPCS J9119 describes the injection of cemiplimab-rwlc, a medication used to treat various types of cancer, including skin cancer and lung cancer.

89. HCPCS Code J9120

HCPCS J9120 describes the injection of dactinomycin, a chemotherapy drug used to treat various types of cancer, including Wilms tumor and rhabdomyosarcoma.

90. HCPCS Code J9130

HCPCS J9130 describes the injection of dacarbazine, a chemotherapy drug used to treat various types of cancer, including melanoma and Hodgkin lymphoma.

91. HCPCS Code J9144

HCPCS J9144 describes the injection of daratumumab and hyaluronidase-fihj, a combination therapy used to treat multiple myeloma.

92. HCPCS Code J9145

HCPCS J9145 describes the injection of daratumumab, a medication used to treat multiple myeloma.

93. HCPCS Code J9150

HCPCS J9150 describes the injection of daunorubicin, a chemotherapy drug used to treat various types of cancer, including leukemia and lymphomas.

94. HCPCS Code J9151

HCPCS J9151 describes the injection of daunorubicin Citrate, liposomal formulation, a chemotherapy drug used to treat acute myeloid leukemia.

95. HCPCS Code J9153

HCPCS J9153 describes the injection of liposomal daunorubicin and cytarabine, a chemotherapy drug used to treat acute myeloid leukemia.

96. HCPCS Code J9155

HCPCS J9155 describes the injection of degarelix, a medication used to treat advanced prostate cancer.

97. HCPCS Code J9165

HCPCS J9165 describes the injection of diethylstilbestrol diphosphate, a medication used to treat prostate cancer.

98. HCPCS Code J9171

HCPCS J9171 describes the injection of docetaxel, a chemotherapy drug used to treat various types of cancer, including breast cancer and lung cancer.

99. HCPCS Code J9172

HCPCS J9172 describes the injection of docetaxel (ingenus), a chemotherapy drug used to treat various types of cancer, including breast cancer and lung cancer.

100. HCPCS Code J9173

HCPCS J9173 describes the injection of durvalumab, a medication used to treat various types of cancer, including lung cancer and bladder cancer.

101. HCPCS Code J9175

HCPCS J9175 describes the injection of Elliotts’ B solution, a medication used to treat bladder cancer.

102. HCPCS Code J9176

HCPCS J9176 describes the injection of elotuzumab, a medication used to treat multiple myeloma.

103. HCPCS Code J9177

HCPCS J9177 describes the injection of enfortumab vedotin-ejfv, a medication used to treat urothelial cancer.

104. HCPCS Code J9178

HCPCS J9178 describes the injection of epirubicin HCl, a chemotherapy drug used to treat various types of cancer, including breast cancer and bladder cancer.

105. HCPCS Code J9179

HCPCS J9179 describes the injection of eribulin mesylate, a chemotherapy drug used to treat various types of cancer, including breast cancer and liposarcoma.

106. HCPCS Code J9181

HCPCS J9181 describes the injection of etoposide, a chemotherapy drug used to treat various types of cancer, including lung cancer and testicular cancer.

107. HCPCS Code J9185

HCPCS J9185 describes the injection of fludarabine phosphate, a chemotherapy drug used to treat various types of cancer, including leukemia and lymphomas.

108. HCPCS Code J9190

HCPCS J9190 describes the injection of fluorouracil, a chemotherapy drug used to treat various types of cancer, including colorectal cancer and breast cancer.

109. HCPCS Code J9196

HCPCS J9196 describes the injection of gemcitabine hydrochloride (accord), a chemotherapy drug used to treat various types of cancer, including pancreatic cancer and lung cancer.

110. HCPCS Code J9198

HCPCS J9198 describes the injection of gemcitabine hydrochloride (infugem), a chemotherapy drug used to treat various types of cancer, including pancreatic cancer and lung cancer.

111. HCPCS Code J9200

HCPCS J9200 describes the injection of floxuridine, a chemotherapy drug used to treat various types of cancer, including colorectal cancer and liver cancer.

112. HCPCS Code J9201

HCPCS J9201 describes the injection of gemcitabine hydrochloride, not otherwise specified, a chemotherapy drug used to treat various types of cancer, including pancreatic cancer and lung cancer.

113. HCPCS Code J9202

HCPCS J9202 describes the goserelin acetate implant, a medication used to treat prostate cancer and breast cancer.

114. HCPCS Code J9203

HCPCS J9203 describes the injection of gemtuzumab ozogamicin, a medication used to treat acute myeloid leukemia.

115. HCPCS Code J9204

HCPCS J9204 describes the injection of mogamulizumab-kpkc, a medication used to treat cutaneous T-cell lymphoma.

116. HCPCS Code J9205

HCPCS J9205 describes the injection of irinotecan liposome, a chemotherapy drug used to treat metastatic pancreatic cancer.

117. HCPCS Code J9206

HCPCS J9206 describes the injection of irinotecan, a chemotherapy drug used to treat various types of cancer, including colorectal cancer and lung cancer.

118. HCPCS Code J9207

HCPCS J9207 describes the injection of ixabepilone, a chemotherapy drug used to treat breast cancer.

119. HCPCS Code J9208

HCPCS J9208 describes the injection of ifosfamide, a chemotherapy drug used to treat various types of cancer, including testicular cancer and sarcomas.

120. HCPCS Code J9209

HCPCS J9209 describes the injection of mesna, a medication used to prevent bladder toxicity caused by chemotherapy drugs.

121. HCPCS Code J9210

HCPCS J9210 describes the injection of emapalumab-lzsg, a medication used to treat primary hemophagocytic lymphohistiocytosis.

122. HCPCS Code J9211

HCPCS J9211 describes the injection of idarubicin hydrochloride, a chemotherapy drug used to treat acute myeloid leukemia.

123. HCPCS Code J9212

HCPCS J9212 describes the injection of interferon alfacon-1, recombinant, a medication used to treat hairy cell leukemia.

124. HCPCS Code J9213

HCPCS J9213 describes the injection of interferon alfa-2a, recombinant, a medication used to treat various types of cancer, including hairy cell leukemia and melanoma.

125. HCPCS Code J9214

HCPCS J9214 describes the injection of interferon alfa-2b, recombinant, a medication used to treat various types of cancer, including hairy cell leukemia and melanoma.

126. HCPCS Code J9215

HCPCS J9215 describes the injection of interferon alfa-N3, a medication used to treat hairy cell leukemia.

127. HCPCS Code J9216

HCPCS J9216 describes the injection of interferon gamma 1-b, a medication used to treat chronic granulomatous disease and osteopetrosis.

128. HCPCS Code J9217

HCPCS J9217 describes the leuprolide acetate for depot suspension, a medication used to treat various types of cancer, including prostate cancer and breast cancer.

129. HCPCS Code J9218

HCPCS J9218 describes the leuprolide acetate, a medication used to treat various types of cancer, including prostate cancer and breast cancer.

130. HCPCS Code J9219

HCPCS J9219 describes the leuprolide acetate implant, a medication used to treat various types of cancer, including prostate cancer and breast cancer.

131. HCPCS Code J9223

HCPCS J9223 describes the injection of lurbinectedin, a chemotherapy drug used to treat small cell lung cancer.

132. HCPCS Code J9225

HCPCS J9225 describes the histrelin implant (Vantas), a medication used to treat prostate cancer and endometriosis.

133. HCPCS Code J9226

HCPCS J9226 describes a histrelin implant called Supprelin LA, which is used for the treatment of certain hormone-related conditions.

134. HCPCS Code J9227

HCPCS J9227 represents an injection called isatuximab-irfc, which is administered to patients for the treatment of multiple myeloma.

135. HCPCS Code J9228

HCPCS J9228 is an injection of ipilimumab, which is used in the treatment of certain types of cancer by stimulating the immune system.

136. HCPCS Code J9229

HCPCS J9229 describes an injection called inotuzumab ozogamicin, which is used for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

137. HCPCS Code J9230

HCPCS J9230 represents an injection of mechlorethamine hydrochloride, also known as nitrogen mustard, which is used in the treatment of certain types of cancer.

138. HCPCS Code J9245

HCPCS J9245 is an injection of melphalan hydrochloride, which is used for the treatment of multiple myeloma and certain types of cancer.

139. HCPCS Code J9246

HCPCS J9246 describes an injection called melphalan (evomela), which is used in the treatment of multiple myeloma and certain types of cancer.

140. HCPCS Code J9247

HCPCS J9247 represents an injection of melphalan flufenamide, which is used for the treatment of relapsed or refractory multiple myeloma.